Suzanne E. Dahlberg

15.1k citations
151 papers · 9.5k · 4 hit papers · h-index 52

Impact in

Papers in

    • Lung Cancer Treatments and Mutations 58
    • Lung Cancer Diagnosis and Treatment 17
    • Lung Cancer Research Studies 17
    • Cancer Treatment and Pharmacology 7
    • Cancer Immunotherapy and Biomarkers 7
    • Colorectal Cancer Treatments and Studies 6

Suzanne E. Dahlberg

146 papers receiving 9.3k citations

Suzanne E. Dahlberg's Hit Papers

Assessment of Resistance Mechanisms and Clinical Implications in Patients WithEGFRT790M–Positive Lung Cancer and Acquired Resistance to Osimertinib 2018 · 521 citations
5210+3+7Years since publication100200300400500

Peers

Suzanne E. Dahlberg
Comparison fields: 5 of 122
  • Oncology 3.6k
  • Pulmonary and Respiratory Medicine 3.9k
  • Cancer Research 1.3k
  • Hematology 574
  • Hepatology 289
Replace Salomon M. Stemmer with:
Salomon M. Stemmer Israel
Alberto S. Pappo United States
Dean F. Bajorin United States
Anthony Elias United States
Michael P. LaQuaglia United States
Thomas M. Ulbright United States
Graça M. Dores United States
George J. Bosl United States
Paul Elson United States
Laurence Brugières France
Suzanne E. Dahlberg relative to Salomon M. Stemmer Israel Salomon M. Stemmer's profile →
Citations per field
00.5×3.3×
Salomon M. Stemmer · 1×
Citations per year

Countries citing papers authored by Suzanne E. Dahlberg

Since Specialization
Citations

This map shows the geographic impact of Suzanne E. Dahlberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne E. Dahlberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne E. Dahlberg more than expected).

Fields of papers citing papers by Suzanne E. Dahlberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne E. Dahlberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne E. Dahlberg. The network helps show where Suzanne E. Dahlberg may publish in the future.

Co-authors

The 25 scholars most cited alongside Suzanne E. Dahlberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Suzanne E. Dahlberg Line = papers co-authored together Suzanne E. Dahlberg links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 151 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Assessment of Resistance Mechanisms and Clinical Implications in Patients WithEGFRT790M–Positive Lung Cancer and Acquired Resistance to Osimertinib
Hit paper breakdown →
2018521
2
MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression
Hit paper breakdown →
2016499
3
Prospective Validation of Rapid Plasma Genotyping for the Detection ofEGFRandKRASMutations in Advanced Lung Cancer
Hit paper breakdown →
2016437
4
Brain metastases in patients with EGFR -mutated or ALK -rearranged non-small-cell lung cancers
Hit paper breakdown →
2015362
5 2009334
6 2013266
7 2018261
8 2019257
9 2015255
10 2007251
11 2013230
12 2012227
13 2015213
14 2013211
15 2019206
16 2015193
17 2011186
18 2010177
19 2018143
20 2011141

About Suzanne E. Dahlberg

Suzanne E. Dahlberg is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Public Health, Environmental and Occupational Health and Cancer Research, having authored 151 papers that have together received 9.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (58 papers), Lung Cancer Research Studies (17 papers), Lung Cancer Diagnosis and Treatment (17 papers), Acute Lymphoblastic Leukemia research (12 papers), Cancer Genomics and Diagnostics (9 papers), Cancer Treatment and Pharmacology (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). The work is most often cited by research in Oncology (3.6k citations), Pulmonary and Respiratory Medicine (3.9k citations), Cancer Research (1.3k citations), Hematology (574 citations) and Hepatology (289 citations). Suzanne E. Dahlberg has collaborated with scholars based in United States, Canada and Israel. Frequent co-authors include Pasi A. Jänne, Geoffrey R. Oxnard, Joan H. Schiller, Lynette M. Sholl, David M. Jackman, Lewis B. Silverman, Stephen E. Sallan, Bruce E. Johnson, Mizuki Nishino and Mark M. Awad. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Blood, Pediatric Pulmonology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact